Bridgefront Capital’s Precigen PGEN Stock Holding History

Bridgefront Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,729	Closed	-$90K	–	597
2021 Q2	$90K	Buy	13,729 +3,097	+29%	+$21.6K	0.03%	558
2021 Q1	$73K	Buy	+10,632	New	+$89.9K	0.02%	630

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Bridgefront Capital's PGEN Position: Q3 2021 in Review

Bridgefront Capital sold out of Precigen (PGEN) in Q3 2021, closing a stake of 13,729 shares — an estimated $90K sold.

Bridgefront Capital first reported a position in PGEN in Q1 2021 and held it in 2 quarters. The position peaked at $90K in Q2 2021. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

Bridgefront Capital reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
Bridgefront Capital sold 13,729 Precigen shares in Q3 2021, an estimated $90K.
Bridgefront Capital first reported a position in Precigen in Q1 2021 and held it in 2 quarters.
Bridgefront Capital's Precigen position peaked at $90K in Q2 2021.
172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Bridgefront Capital's 13F filing for Q3 2021, filed 12 Nov 2021.